FDA-cleared profile

SMART Bun-Yo-Matic CT

Disior Ltd

Foot and ankle CT analysis for three-dimensional visualization, measurements, and preoperative surgical planning by qualified orthopaedic professionals.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
Foot and ankle CT analysis for three-dimensional visualization, measurements, and preoperative surgical planning by qualified orthopaedic professionals.
FDA source Exact FDA submission Checked 2026-09-08
Intended users
Qualified orthopaedic professionals.
FDA source Exact FDA submission Checked 2026-09-08
Care setting and population
Orthopaedic clinical and preoperative-planning workflows.
FDA source Exact FDA submission Checked 2026-09-08
Workflow role
CT-based three-dimensional measurement, visualization, and surgical-planning support.
FDA source Exact FDA submission Checked 2026-09-08
Required input
Eligible CT image series of the foot and ankle meeting labeled acquisition and quality requirements.
FDA source Exact FDA submission Checked 2026-09-08
Output and human action
Three-dimensional models, measurements, metal-detection results, and planning parameters for professional review.
FDA source Exact FDA submission Checked 2026-09-08
Limitations
Outputs support professional planning and do not prescribe the surgical procedure; users must review measurements and apply clinical judgment.
FDA source Exact FDA submission Checked 2026-09-08

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K240642
FDA source Exact FDA submission Checked 2026-08-31
Modality
CT/CTA
FDA source Exact FDA submission Checked 2026-09-08
Anatomy
Foot/Ankle
FDA source Exact FDA submission Checked 2026-09-08
Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2024-06-20
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
The exact FDA summary establishes CT image-series processing and a software planning workflow; exact hosting and PACS or EHR interfaces require vendor confirmation.
FDA source Exact FDA submission Checked 2026-09-08
Deployment and data flow
Hybrid
Public source Exact FDA submission Checked 2026-08-13

Deployment category preserved from the prior exact-submission review; hosting region, data flow, and current commercial configuration still require vendor confirmation.

Security and privacy
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-08

Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.

Training and support
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-08

Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

Monitoring and change control
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-08

Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

Current product-family workflow context

Paragon 28 publishes a current-family IFU describing foot and ankle measurement and surgical-planning workflows and their visualization-only boundaries.

product family · checked 2026-09-08

Confirm exact-release availability, interfaces, hosting, security, support, and commercial terms during procurement.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
FDA-described testing used 82 CT image series. Foot and ankle bones were correctly identified in all test series; metal presence detection was reported with 100% sensitivity and 98% specificity. The summary states that component testing met the predetermined acceptance criteria and that clinical data were not needed for the substantial-equivalence determination.
FDA source Exact FDA submission Checked 2026-09-08
Reported sensitivity
100% sensitivity for the metal-presence detection component; this is not patient-level disease-detection sensitivity.
FDA source Exact FDA submission Checked 2026-09-08
Reported specificity
98% specificity for the metal-presence detection component; this is not patient-level disease-detection specificity.
FDA source Exact FDA submission Checked 2026-09-08

Foot and ankle bone identification

100 percent

CT image series with correctly identified foot and ankle bones in CT component test set.

Tested version: SMART Bun-Yo-Matic CT configuration submitted in K240642

Metal-presence detection sensitivity

100 percent

Sensitivity for identifying metal presence in CT images in CT component test set.

Tested version: SMART Bun-Yo-Matic CT configuration submitted in K240642

Metal-presence detection specificity

98 percent

Specificity for identifying metal presence in CT images in CT component test set.

Tested version: SMART Bun-Yo-Matic CT configuration submitted in K240642

SMART Bun-Yo-Matic CT component performance testing

Nonclinical component testing of bone identification, metal identification, segmentation, measurements, and surgical-planning calculations. · 82 CT image series in the held-out component test set; the FDA summary states that clinical data were not required.

exact submission · Tested version: SMART Bun-Yo-Matic CT configuration submitted in K240642 · n=82 · Sponsor or vendor study

K240642

FDA submission evidence; component metrics are not diagnostic accuracy for a disease endpoint.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-08

No public price or quote for the exact K240642 configuration was established in this review.

Reimbursement and coding
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-08

No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K240642. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
Public source Exact FDA submission Checked 2026-09-08

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-08Last searched
20Fields reviewed
9Source classes checked
0Unreviewed PubMed leads
0Unreviewed trial leads
0Unreviewed FDA recall leads

Recovered from the prior exact-submission extraction and normalized under the current provenance rules. Exact FDA scope controls clinical claims. ACR and official vendor material provide bounded catalog or product-family context. Candidate literature metadata remains a discovery queue until full-text identity, endpoint, population, and version review is completed. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, fda decision summary, vendor instructions for use, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-08.

Alternatives

Related tools to compare

FDA-cleared K223757

Bonelogic

Disior Ltd

Bonelogic 2.2 assists orthopedic healthcare professionals with diagnosis and surgical planning by semi-automatically segmenting bony structures from CT and producing foot and...

Modality
CT/CTA
Anatomy
Foot/ankle
Decision
2023-12-08
FDA-cleared K221432

Customize

3D-Side SA

Customize supports adult total ankle arthroplasty planning with CT segmentation, three-dimensional models, implant positioning and sizing, treatment-plan review, and...

Modality
CT/CTA
Anatomy
Foot/Ankle
Decision
2022-08-03